Sagittarius Life Science Corp (TPEX:3205)

Market Cap	3.65B
Revenue (ttm)	446.03M
Net Income (ttm)	-54.24M
Shares Out	67.55M
EPS (ttm)	-1.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	243,023
Average Volume	523,174
Open	53.70
Previous Close	54.10
Day's Range	52.20 - 54.60
52-Week Range	21.30 - 61.60
Beta	0.78
RSI	55.89
Earnings Date	Nov 13, 2025

About Sagittarius Life Science

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 112
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3205

Financial Performance

In 2024, Sagittarius Life Science's revenue was 467.75 million, an increase of 6.20% compared to the previous year's 440.46 million. Losses were -48.53 million, -11.82% less than in 2023.